Walgreens completes 31 Drug Fair location buys
Walgreens, the USA's largest drugstore chain, has completed the acquisition of 31 Drug Fair stores in central and western New Jersey. The announcement follows an agreement reached in March associated with Drug Fair's Chapter 11 process. Terms of the transaction were not disclosed.
In addition, Walgreens has purchased the prescription files for the following Drug Fair locations at: 449 Lakeview Avenue, Clifton, NJ; and 2960 Route 10 West, Morris Plains, NJ.
Patients previously served by these pharmacies have immediate access to their prescription histories at any nearby Walgreens. The firm also expects to complete transactions for two additional Drug Fair locations in the upcoming weeks.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze